More Doc Visits Good for Diabetics

Patients who visited their primary care physician once every one or two weeks to control their diabetes reached their clinical goals more often than those who visited less frequently, says a new study in the Archives of Internal Medicine.

More frequent patient-physician interactions led to faster control of hemoglobin A1c levels and low density lipoprotein (LDL) levels, and improved outcomes.

The retrospective study included 26,496 patients with diabetes. The patients were separated into two groups. Patients not receiving insulin who visited their doctor every one to two weeks took a median of 4.4 months to achieve hemoglobin A1c levels of less than 7 percent.

In contrast, patients who saw their physicians every three to six months took 24.9 months for their levels to come in line.

For patients who were receiving insulin, it was 10.1 months vs. 52.8 months.

Reaching acceptable clinical outcomes faster was also evident when the researchers looked at blood pressure and LDL levels.

The median time to reach a blood pressure lower than 130/85 mm Hg was 1.3 months compared with 13.9 months.

Median time to reach LDL levels less than 100 mg/dL was 5.1 months vs. 32.8 months.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to or online at

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.